Bolus-only versus bolus plus continuous infusion hydromorphone for refractory cancer pain: a prospective, multicenter, randomized noninferiority trial.
Yan Z, Fu Y, Jin Y, Zhao W, Gong L, Xie G, Zhou L, Tian D, Feng Z
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.